glp-1 patent Ozempic's problem: how Novo Nordisk lost control of a blockbuster drug. 💉 Demand for weight-loss drugs has exploded, turning Ozempic into a $40bn+ revenue engine for Novo Nordisk. But, despite The GLP-1 effect on MedTech

Nutritional deficiencies and weight regain are both risks after surgery if patients do not pay attention to proper diet

Most positively and negatively discussed food and drinks Some food and drink items were discussed with enthusiasm and satisfaction, while others showed up in posts marked by frustration, discomfort, or regret

So when people either engage in repeated dieting or in use of one of these drugs, it has to be either a lifelong change in diet and exercise habits, or a lifelong commitment to take one of these drugs

We hypothesize that GE2 treatment will mitigate the cognitive and inflammatory impacts of a WD and enhance cognition, reduce inflammation, and increase neuroplasticity in limbic regions of the brain in middle-aged male and female rats

(May 2002)